Plant Health Care plc (LON:PHC)‘s stock had its “buy” rating reaffirmed by stock analysts at Liberum Capital in a research note issued to investors on Monday, October 30th. They currently have a GBX 45 ($0.59) price objective on the stock. Liberum Capital’s target price indicates a potential upside of 100.00% from the stock’s previous close.
Plant Health Care plc (PHC) traded down GBX 0.50 ($0.01) during trading on Monday, reaching GBX 22.50 ($0.30). Plant Health Care plc has a 12-month low of GBX 13 ($0.17) and a 12-month high of GBX 35 ($0.46).
COPYRIGHT VIOLATION WARNING: “Plant Health Care plc’s (PHC) “Buy” Rating Reiterated at Liberum Capital” was originally posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this report on another domain, it was stolen and republished in violation of US & international copyright and trademark laws. The correct version of this report can be accessed at https://www.dispatchtribunal.com/2017/11/18/liberum-capital-reaffirms-buy-rating-for-plant-health-care-plc-phc.html.
About Plant Health Care plc
Plant Health Care plc provides agricultural biological products and technology solutions. The Company’s segments include Americas, Mexico, Rest of World and New Technology. The Company focuses on businesses, including New Technology and Commercial. Its Commercial business is focused on the sale of biological products.
Receive News & Ratings for Plant Health Care plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plant Health Care plc and related companies with MarketBeat.com's FREE daily email newsletter.